  name: Drug Central Resource Ingest Guide

# Information about the Source of the ingest data
  source_info:  
    infores_id:  infores:drugcentral 
    description: >-
      DrugCentral is an open-access, manually curated drug information resource developed/maintained by the Translational Informatics Division at the University of New Mexico. 
      It provides  information about drug active pharmaceutical ingredients (for human and increasingly veterinary use), including chemical structure, regulatory status,
      pharmacology, target biology, indications, adverse events, and more. The majority of knowledge in DrugCentral is manually curated - either by the DrugCentral team, or 
      by external sources from which DrugCentral imports (and vets) data. 
    citations:
      - Avram SD, Ursu O, Holmes J et al. DrugCentral 2023: updated content, data sources, and functionality. Nucleic Acids Research. 2023 Jan;51(D1):D1276â€“D1283. PMID: 36484092
    terms_of_use_info:  
      terms_of_use_url: https://drugcentral.org/privacy
      terms_of_use_description: From 2021 publication: "DrugCentral data are freely available for download and re-use without restriction."
      license name:  CC-BY-SA
    data_access_locations:  https://drugcentral.org/download
    data_provision_mechanisms:  # (optional, multivalued, range = ProvisionMechanismEnum: file_download | api_endpoint | database_dump | other)
    data_formats:  
      - tsv
      - csv
      - postgres
    data_versioning_and_releases: Dated releases

# Information about Ingested Content (the scope, content, and rationale for what is included and excluded in this ingest)
  ingest_info:
    ingest_categories: 
      - primary_knowledge_provider
    scope: Curated drug bioactivities (interaction/affect on biological targets) and therapeutic relationships to diseases 
    utility: Drug bioactivities (interaction/affect on biological targets) and therapeutic relationships to diseases are core Translator knowledge types key to its query use cases.
      
    relevant_files:
      - file_name:  drug.target.interaction.tsv
        location:   https://drugcentral.org/download
        description:  Drug-target interaction data extracted from literature, drug labels, and external data sources in TSV format
      - file_name:  # COLLEEN TO ADD WHAT FILE WAS USED FOR DRUG-DISEASE THERAPEUTIC RECORDS
        location:   # COLLEEN TO DO
        description:  # COLLEEN TO DO
        
    included_content:
      - file_name: drug.target.interaction.tsv
        included_records:   Only ingested records where there is a MoA, and the source is not Chembl or GtoPdb (b/c we get these directly).  This is because these without MoA are primarily based on curation or import of experimental data and Vlado does not think the Kd/Ki/IC50 values reported are always indicative of a meaningful interaction.  If we want to take these we need to establish some rules / thresholds for what qualifies as a meaningful interaction. 
        fields_used:  
      - file_name:     # COLLEEN TO ADD WHAT FILE(S) USED FOR DRUG-DISEASE THERAPEUTIC RECORDS
        included_records:  # COLLEEN TO DO (do we take all records, or do we apply a filter?)
        fields_used:  

    future_considerations:  # TO DO - COlleen to note any content additions/changes to consider for future iterations.
      - category:  # (required, range = ContentCategoryEnum: edge_content | node_property_content | edge_property_content | other)
        consideration:  # (required, range = string)
        relevant_files:  # (optional, range = string)

    additional_notes:  # (optional, range = string)

# Information about the Graph Output by the ingest
  target_info:
    infores_id: infores:translator-drugcentral

    edge_type_info:
      - subject_categories: 
          - ChemicalEntity
        predicates:  
          - biolink:affects
        object_categories: 
          - Protein
        qualifiers:
          - property: "biolink:qualified_predicate"
            value_enumeration:
              - "biolink:causes"        
          - property: "biolink:object_direction_qualifier"
            value_range:
              - "biolink:DirectionQualifierEnum"
          - property: "biolink:object_aspect_qualifier"
            value_range:
              - "biolink:GeneOrGeneProductOrChemicalEntityAspectEnum"
          - property: "biolink:causal_mechanism_qualifier"
            value_range:
              - "biolink:CausalMechanismQualifierEnum"
        knowledge_level:
          - knowledge_assertion
        agent_type:
          - manual_agent
        edge_properties:  
          -    # COLLEEN TO DO, IF ANY
        ui_explanation:  # TO DO
        additional_notes: >-
          The 'mechanism of action' reported by DrugCentral determines that type of edge is created: (1) an 'affects' edge when the mechanism implies an effect of the subject on the object - e.g. 'positive modulator' implies that 'A causes increased activity of B'; a 'directly_physically_interacts_with' edge when the mechanism implies only that the subject interacts with B, but not an effect that results from this - e.g. 'binding agent' implies only a physical interaction; (or (3) both 'affects' and 'directly_physically_interacts_with' edges, when the mechanism implies an effect that is necessarily mediated through a direct physical interaction - e.g. 'antagonist' implies that 'A decreases the activity of B' and that 'A directly physically interacts with B'. A full mapping of these Drug Central mechanisms to Biolink predicate and qualifier combinations can be found here: https://docs.google.com/spreadsheets/d/1DeAE04O1mz3R9s3dCZpG2hQp9hwif5WjdkUMsBci-u8/edit?gid=392679103#gid=392679103.
           Primary knowledge source set to DrugCentral, and sources reported in 'bioactivity source' or 'moa source' columns by DrugCentral are reported as supporting data sources. This is because they often do things like combine bioactivity info with MoA info from different sources into a new record - which would make it impossible to reporting a single upstream source as primary.
      - subject_categories: 
          - ChemicalEntity
        predicates:  
          - biolink:directly_physically_interacts_with
        object_categories: 
          - Protein
        qualifiers:
          - property: "biolink:causal_mechanism_qualifier"
            value_range:
              - "biolink:CausalMechanismQualifierEnum"
        knowledge_level:
          - knowledge_assertion
        agent_type:
          - manual_agent
        edge_properties:  
          -    # COLLEEN TO DO, IF ANY
        ui_explanation:  # TO DO
        additional_notes: >-
          The 'mechanism of action' reported by DrugCentral determines that type of edge is created: (1) an 'affects' edge when the mechanism implies an effect of the subject on the object - e.g. 'positive modulator' implies that 'A causes increased activity of B'; a 'directly_physically_interacts_with' edge when the mechanism implies only that the subject interacts with B, but not an effect that results from this - e.g. 'binding agent' implies only a physical interaction; (or (3) both 'affects' and 'directly_physically_interacts_with' edges, when the mechanism implies an effect that is necessarily mediated through a direct physical interaction - e.g. 'antagonist' implies that 'A decreases the activity of B' and that 'A directly physically interacts with B'. A full mapping of these Drug Central mechanisms to Biolink predicate and qualifier combinations can be found here: https://docs.google.com/spreadsheets/d/1DeAE04O1mz3R9s3dCZpG2hQp9hwif5WjdkUMsBci-u8/edit?gid=392679103#gid=392679103.

      - subject_categories: 
          - ChemicalEntity
        predicates:  
          - biolink:treats
          - biolink:applied_to_treat
          - biolink:preventative_for
          - biolink:contraindicated_in          
        object_categories: 
          - DiseaseOrPhenotypicFeature
        knowledge_level:
          - knowledge_assertion          
        agent_type:
          - manual_agent
        edge_properties:  
          -  biolink:clinical_approval_status
        ui_explanation:  # TO DO
        additional_notes: >-
          DrugCentral.indication, symptomatic_treatment, and off_label-use -> biolink:treats (some reading of DrugCentral papers suggested that off-label use reports are based on widely established clinical use, not just anecdotal reports, warranting a 'treats' mapping to set these apart from 'applied to treat' edges based on anecdotal/patient self-report data from sources like faers)
          DrugCentral.reduce_risk -> biolink.preventative_for
          DrugcCentral.contraindication -> biolink:contraindicated_in
          DrugCentral.diagnosis -> biolink.diagnoses (or just drop these, only a couple records, and not very useful?)
        
    node_type_info:  # (required, multivalued, range = NodeType)
      - node_category: ChemicalEntity
        source_identifier_types: 
          - internal DrugCentral structure id 
        additional_notes:  e.g. "1423" for imatinib.  Not sure if/where we have mappings form these to caononical chemical / drug identifiers?
      - node_category: Protein
        source_identifier_types: 
          - UNIPROT
      - node_category: DiseaeOrPhenotypicFeature
        source_identifier_types: 
          - ????  # COLLEEN TO DO          
    future_considerations:  # Colleen to note any possible changes/additions to modeling in future iteration of the ingest
      - category:  # (optional, range = ModelingCategoryEnum: spoq_pattern | predicates | qualifiers | edge_properties | node_properties | other)
        consideration:  # (required, range = string)

    additional_notes:  # (optional, range = string)


# Information about how the ingest was specified and performed
  provenance_info:  # (optional, range = ProvenanceInformation)
    contributions:
    - "Colleen Xu - code author"
    - "Sierra Moxon - code support"
    - "Matthew Brush - data modeling, domain expertise"
